\-\ Texto\\:\\ \ \(0\)\
\-\ treatment\\ usually\\ consists\\ of\\ curettage\\ or\\ excision\\ with\\ wide\\ margins\\ and\\ the\\ use\\ of\\ adjuvants\\ such\\ as\\ phenol\\ and\\ argon\\ beam\\ coagulation\\.\\ bone\\ cement\\ also\\,\\ theoretically\\ decrease\\ recurrence\\ and\\ provides\\ stability\\ to\\ the\\ resected\\ area\\.\\ recurrence\\ rates\\ with\\ these\\ measures\\ vary\\ between\\ 5\\%\\ and\\ 15\\%\\.\ \(0\)\
\-\ geographic\\,lytic\\,eccentric\\,\\ expansile\\ lesion\\ at\\ the\\ femoral\\ metaphysis\\ extending\\ to\\ the\\ joint\\ surface\\.\ \(0\)\
\-\ giant\\ cell\\ tumor\ \(18\)\
\-\ giant\\ cell\\ tumor\ \(18\)\
\-\ osteosarcoma\ \(92\)\
\-\ mets\ \(38\)\
\-\ multiple\\ myeloma\ \(25\)\
\-\ malignant\\ fibrous\\ histiocytoma\ \(11\)\
\-\ patient\\ complains\\ of\\ chronic\\ knee\\ pain\\ for\\ several\\ months\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ giant\\:\\ 0\\.2378659064309193\ \(0\)\
\-\ recurrence\\:\\ 0\\.22016916462934066\ \(0\)\
\-\ adjuvants\\:\\ 0\\.2132289131047376\ \(0\)\
\-\ phenol\\:\\ 0\\.2132289131047376\ \(0\)\
\-\ argon\\:\\ 0\\.2132289131047376\ \(0\)\
\-\ theoretically\\:\\ 0\\.2037516099391586\ \(0\)\
\-\ cement\\:\\ 0\\.17807275000046136\ \(0\)\
\-\ geographic\\:\\ 0\\.15940850647920357\ \(0\)\
\-\ beam\\:\\ 0\\.15614172403008045\ \(0\)\
\-\ coagulation\\:\\ 0\\.15514693961980391\ \(0\)\
\-\ histiocytoma\\:\\ 0\\.15419277017302416\ \(0\)\
\-\ cell\\:\\ 0\\.15254553801856285\ \(0\)\
\-\ vary\\:\\ 0\\.14993120331362453\ \(0\)\
\-\ eccentric\\:\\ 0\\.14916477708995005\ \(0\)\
\-\ curettage\\:\\ 0\\.14700565182420913\ \(0\)\
\-\ provides\\:\\ 0\\.14632809987343084\ \(0\)\
\-\ tumor\\:\\ 0\\.139482064191635\ \(0\)\
\-\ rates\\:\\ 0\\.1389453828466857\ \(0\)\
\-\ myeloma\\:\\ 0\\.13846342957383753\ \(0\)\
\-\ mets\\:\\ 0\\.1370744721526549\ \(0\)\
\-\ stability\\:\\ 0\\.13452205820944887\ \(0\)\
\-\ consists\\:\\ 0\\.13258922984845217\ \(0\)\
\-\ wide\\:\\ 0\\.12914567587151976\ \(0\)\
\-\ osteosarcoma\\:\\ 0\\.1261449066000213\ \(0\)\
\-\ metaphysis\\:\\ 0\\.12250160726752904\ \(0\)\
\-\ resected\\:\\ 0\\.1220245722283889\ \(0\)\
\-\ expansile\\:\\ 0\\.12064923993473359\ \(0\)\
\-\ complains\\:\\ 0\\.11601957246602829\ \(0\)\
\-\ decrease\\:\\ 0\\.11460253827797268\ \(0\)\
\-\ margins\\:\\ 0\\.1137586233073738\ \(0\)\
\-\ lytic\\:\\ 0\\.11231235346120869\ \(0\)\
\-\ surface\\:\\ 0\\.11124625767632197\ \(0\)\
\-\ and\\:\\ 0\\.11020674501943814\ \(0\)\
\-\ measures\\:\\ 0\\.108709250021015\ \(0\)\
\-\ the\\:\\ 0\\.10641926843776654\ \(0\)\
\-\ excision\\:\\ 0\\.10512523511239365\ \(0\)\
\-\ fibrous\\:\\ 0\\.1035737905159354\ \(0\)\
\-\ use\\:\\ 0\\.10201841158086979\ \(0\)\
\-\ femoral\\:\\ 0\\.09909876184773148\ \(0\)\
\-\ knee\\:\\ 0\\.09557167117570345\ \(0\)\
\-\ malignant\\:\\ 0\\.09504470090320374\ \(0\)\
\-\ extending\\:\\ 0\\.09040166146828352\ \(0\)\
\-\ 15\\:\\ 0\\.0900984937212926\ \(0\)\
\-\ joint\\:\\ 0\\.08785977204486957\ \(0\)\
\-\ several\\:\\ 0\\.08747970016482266\ \(0\)\
\-\ between\\:\\ 0\\.08663349352251144\ \(0\)\
\-\ area\\:\\ 0\\.08637521569446634\ \(0\)\
\-\ such\\:\\ 0\\.08576674995338554\ \(0\)\
\-\ usually\\:\\ 0\\.08393822868020913\ \(0\)\
\-\ chronic\\:\\ 0\\.07914281369129776\ \(0\)\
\-\ of\\:\\ 0\\.07827818779514113\ \(0\)\
\-\ months\\:\\ 0\\.07761074585332471\ \(0\)\
\-\ these\\:\\ 0\\.07529327210805087\ \(0\)\
\-\ bone\\:\\ 0\\.0727507836244529\ \(0\)\
\-\ to\\:\\ 0\\.06666610732155401\ \(0\)\
\-\ multiple\\:\\ 0\\.06521620044321384\ \(0\)\
\-\ lesion\\:\\ 0\\.06392293201481389\ \(0\)\
\-\ treatment\\:\\ 0\\.06351370770817688\ \(0\)\
\-\ also\\:\\ 0\\.06271614533282051\ \(0\)\
\-\ as\\:\\ 0\\.05356470350173909\ \(0\)\
\-\ with\\:\\ 0\\.05221663932913071\ \(0\)\
\-\ at\\:\\ 0\\.05036166111399972\ \(0\)\
\-\ pain\\:\\ 0\\.047711548079216966\ \(0\)\
\-\ or\\:\\ 0\\.04638426776071433\ \(0\)\
\-\ patient\\:\\ 0\\.043366616735058885\ \(0\)\
\-\ for\\:\\ 0\\.04041228850379844\ \(0\)\
